Dr. Stemmer-Rachamimov is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
55 Fruit St
WRN 3
Boston, MA 02114Phone+1 617-726-5510Fax+1 617-724-1813
Education & Training
Massachusetts General HospitalFellowship, Neuropathology, 1999 - 2001
University of Milan Faculty of MedicineClass of 1982
Certifications & Licensure
MA State Medical License 1995 - 2024- American Board of Pathology Anatomic Pathology
- American Board of Pathology Neuropathology
Publications & Presentations
PubMed
- 620 citationsDefining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma.Moshe Sade-Feldman, Keren Yizhak, Stacey L Bjorgaard, John P Ray, Carl G de Boer
Cell. 2018-11-01 - 88 citationsAn update on the CNS manifestations of neurofibromatosis type 2Shannon Coy, Rumana Rashid, Anat Stemmer-Rachamimov, Sandro Santagata
Acta Neuropathologica. 2020-04-01 - 84 citationsUpdated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: An international consensus recommendation.Scott R Plotkin, Ludwine Messiaen, Eric Legius, Patrice Pancza, Robert A Avery
Genetics in Medicine. 2022-09-01
Press Mentions
Antiangiogenesis Treatment Improves Hearing in Some NF2 PatientsJuly 8th, 2009
Grant Support
- Neuropathology CoreNational Institute Of Neurological Disorders And Stroke2008–2012
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
